CompletedPhase 3

Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

United States, Canada, Italy19 participantsStarted 2009-10-29

Plain-language summary

This was a long term follow on study to assess the continued long term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Completed UP1002 or 733-005.
✓. Willing and able to provide consent and comply with the requirements of the study protocol.

Exclusion criteria

✕. Met any of the stopping rules for study discontinuation at the final visit of study UP1002 or 733-005.

What they're measuring

Percent Change in Low Density Lipoprotein Cholesterol (LDL-C)

Timeframe: Baseline and Week 126

Trial details

NCT IDNCT00943306

SponsorAegerion Pharmaceuticals, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2012-09-17

Results submitted2016-02-29

View on ClinicalTrials.gov More Familial Hypercholesterolemia trials